Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20355)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | GR50 | GRmax | GR_AOC | GEC50 | GRinf | GR Hill Coefficient | GR r2 | pval_GR |
---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Rucaparib | inf | 0.7324 | 0.1120 | 0.0074 | 0.8618 | 5.0000 | 0.2180 | 0.046276083 |
MDA-MB-157 | Ribociclib | inf | 0.5908 | 0.0808 | 0.0790 | 0.8320 | 5.0000 | 0.2263 | 0.040460682 |
SUM149PT | SHP099 | 31.82140091 | 0.7648 | -0.0244 | 70.8992 | -0.9990 | 1.3705 | 0.2286 | 0.038994512 |
HCC1428 | Rucaparib | 0.023670881 | -0.2500 | 0.7420 | 7.6534 | -1.0000 | 0.1901 | 0.2290 | 0.038773048 |
HCC1937 | Rucaparib | inf | 0.7658 | 0.0636 | 0.0095 | 0.8675 | 5.0000 | 0.2293 | 0.038523875 |
HCC1428 | Ulixertinib | 0.227625258 | 0.1375 | 0.4320 | 0.1734 | 0.1614 | 1.4315 | 0.2319 | 0.036949884 |
SUM1315MO2 | Senexin B | inf | 0.7371 | 0.2113 | 0.5888 | 0.5399 | 0.2353 | 0.2333 | 0.036109414 |
CAL-51 | Senexin B | 49184874.89 | 0.7426 | 0.1286 | 1000.0000 | 0.4054 | 0.1541 | 0.2466 | 0.029016792 |
HCC1143 | Rucaparib | 212371.6019 | 0.7856 | 0.0507 | 630.9562 | 0.3840 | 0.2511 | 0.2497 | 0.027576264 |
CAMA-1 | Rucaparib | inf | 0.8528 | 0.1254 | 0.0108 | 0.8301 | 5.0000 | 0.2588 | 0.023653062 |
CAL-51 | GSK2334470 | 22.73047392 | 0.8334 | 0.0336 | 53.5738 | -0.9998 | 1.2813 | 0.2592 | 0.023515658 |
MDA-MB-157 | GSK2334470 | 76.35127426 | 0.4545 | 0.1687 | 498.7726 | -0.2137 | 0.1896 | 0.2637 | 0.021778256 |
SUM1315MO2 | AZD5363 | inf | 0.5993 | 0.2010 | 0.1377 | 0.6619 | 0.3406 | 0.2935 | 0.013005042 |
HCC1428 | GSK2334470 | 0.261068206 | 0.2500 | 0.4172 | 0.2322 | 0.2218 | 5.0000 | 0.2993 | 0.01172251 |
CAL-85-1 | Ulixertinib | 3.83746694 | 0.2311 | 0.2960 | 72.1557 | -1.0000 | 0.3744 | 0.3008 | 0.011412092 |
MDA-MB-453 | SHP099 | 11.54207272 | 0.7015 | 0.0178 | 14.3805 | -1.0000 | 4.9966 | 0.3055 | 0.010499523 |
CAL-85-1 | Rucaparib | 15.9069887 | 0.3496 | 0.2765 | 1000.0000 | -0.6758 | 0.2065 | 0.3127 | 0.009204617 |
HCC1806 | GSK2334470 | 44.5159354048 | 0.8389 | 0.0198 | 86.1125 | -0.5419 | 1.1127 | 0.3134 | 0.00908806432112 |
SUM1315MO2 | SHP099 | 22.32790504 | 0.4783 | 0.1197 | 419.3194 | -1.0000 | 0.3746 | 0.3197 | 0.008107411 |
SUM1315MO2 | Rucaparib | 17.80541463 | 0.2942 | 0.3317 | 1000.0000 | -0.3226 | 0.1236 | 0.3203 | 0.008018079 |
HCC1806 | Ribociclib | 168.232015049 | 0.6251 | 0.1419 | 317.3038 | -0.1285 | 0.3606 | 0.3213 | 0.00787309835959 |
SUM159PT | SHP099 | 3294.604776 | 0.8118 | 0.0447 | 1000.0000 | 0.1710 | 0.3511 | 0.3261 | 0.007206359 |
HCC38 | GSK2334470 | 362.2276812 | 0.7326 | 0.0411 | 1000.0000 | -0.2309 | 0.3738 | 0.3294 | 0.006774661 |
MDA-MB-436 | GSK2334470 | 26.4830237 | 0.7307 | 0.0123 | 64.9192 | -0.9964 | 1.2226 | 0.3331 | 0.006324926 |
MDA-MB-361 | Rucaparib | inf | 0.1133 | 0.3149 | 0.0128 | 0.5095 | 5.0000 | 0.3359 | 0.005993375 |